NIH-funded research R21 grant

Injectable hydrogel to help regenerate damaged neural tissues

Official title: Bioelectronics-embedded injectable hydrogel for neural regeneration

Funded at University of New Hampshire · NIH-10647492 · Data updated 2026-11-12

This study is testing a new gel that can help deliver special cells to heal damaged nerves, like those hurt in spinal cord injuries, and it aims to improve recovery and restore movement for patients.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of New Hampshire
NIH-funded
Lab location1 site (Durham, United States)
Project startSeptember 21, 2023
Project endSeptember 20, 2025
Funding year2023
Award (this year)$426,509
NIH project number1R21EB034527-01
Project IDNIH-10647492 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from spinal cord injuries or other neural damage who are seeking innovative treatment options.

Less likely to help

Patients with non-neural injuries or those who do not have the capacity for neural regeneration may not benefit from this research.

What this research studies

This research focuses on developing a new type of injectable hydrogel designed to deliver neural stem cells (NSCs) for the regeneration of damaged neural tissues, such as those affected by spinal cord injuries. The hydrogel is made from composite microgels that allow for better cell viability and promote essential cell-to-cell interactions necessary for the differentiation of NSCs into neurons. By using a dual crosslinking mechanism, the hydrogel creates a microporous structure that supports the growth and integration of these cells into the host tissue, potentially leading to improved recovery of neural function. Patients receiving this treatment could benefit from enhanced healing and restoration of neural pathways.

Why it matters

Potential benefit: If successful, this research could significantly improve recovery outcomes for patients with neural injuries by enhancing the regeneration of damaged tissues.

How similar studies have gone: While the approach of using injectable hydrogels for cell delivery is being explored, this specific microporous formulation represents a novel advancement in the field.

Where this research is happening

  • University of New Hampshire
    Durham, United States
    Active

Researchers

  • Principal investigator: Jeong, Kyung Jae — University of New Hampshire
  • Study coordinator: Jeong, Kyung Jae

Related research

Other NIH-funded projects on the same topics.

  • Calcium signaling proteins and heart disease: mapping how ions shape structure and function

    A research program will study how calcium-binding proteins in the heart change shape and behavior when ions bind, to understand a form of heart disease.

    NIH research University of New Hampshire · Durham, United States · NIH-11626552

  • New iris-to-lens reprogramming to study eye tissue regeneration

    A project at the University of New Hampshire is exploring how eye tissues can regenerate by reprogramming iris cells to lens-like tissue to understand and potentially treat degenerative eye diseases.

    NIH research University of New Hampshire · Durham, United States · NIH-11626549

  • Expansion of New Hampshire’s Workplace Health Surveillance Program

    A state health program is expanding to track and respond to workplace injuries, illnesses, hazards, and deaths, with a focus on lead exposure, opioid overdoses, suicide, infectious diseases, and worker well-being.

    NIH research University of New Hampshire · Durham, United States · NIH-11584750

  • C1ORF150 control of human mast cell activation in urticaria

    A study in people with chronic hives to understand how a specific gene variant (C1ORF150) affects mast cell activation and how this could lead to better treatments.

    NIH research University of New Hampshire · Durham, United States · NIH-11454839

  • Data Science Core to boost multi-omics biomedical research

    A Data Science Core project at UNH aims to strengthen how researchers design experiments, analyze data, and share large multi-omics datasets to accelerate biomedical and bioengineering breakthroughs.

    NIH research University of New Hampshire · Durham, United States · NIH-11415037

  • Molecular and Cellular Phenotyping Core for Biomedical Research

    This grant funds a core facility at UNH that accelerates biomedical and bioengineering research by providing advanced imaging, proteomics, and material-mechanics tools to researchers and students.

    NIH research University of New Hampshire · Durham, United States · NIH-11415033

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.